Inventiva (IVA) Free Cash Flow (2019 - 2025)
Inventiva (IVA) recorded quarterly Free Cash Flow of -$60.8 million in Q2 2025, down 17.31% quarter-over-quarter from -$51.8 million in Q2 2024, and down 17.31% on a YoY basis from -$73.5 million in Q2 2024.
Inventiva (IVA) Free Cash Flow (2019 - 2025) Analysis & Trends
Inventiva's Free Cash Flow history runs 6 years deep, the most recent figure standing at -$60.8 million for Q2 2025.
- In Q2 2025, Free Cash Flow fell 17.31% year-over-year to -$60.8 million; the TTM figure through Dec 2025 stood at -$112.5 million (down 117.31% YoY), while the FY2025 annual figure was -$122.4 million, down 32.76% from the prior year.
- Free Cash Flow was -$60.8 million for Q2 2025 at Inventiva, down from -$51.8 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$9.3 million in Q1 2021 to a low of -$60.8 million in Q2 2025.
- Historically, Free Cash Flow has averaged -$30.3 million across 4 years, with a median of -$26.4 million in 2022.
- The sharpest annual moves came in 2021 and 2025: Free Cash Flow slumped 262.03% in 2021, then dropped 17.31% in 2025.
- A 4-year view of Free Cash Flow shows it stood at -$22.5 million in 2021, then retreated by 17.76% to -$26.4 million in 2022, then slumped by 95.78% to -$51.8 million in 2024, then decreased by 17.31% to -$60.8 million in 2025.
- The last three Free Cash Flow figures came in at -$60.8 million (Q2 2025), -$51.8 million (Q2 2024), and -$26.4 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 63,220.27 |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -60.75 Mn |
| Jun 30, 2025 | -60.75 Mn |
| Jun 30, 2024 | -51.78 Mn |
| Jun 30, 2024 | -51.78 Mn |
| Dec 31, 2022 | -26.45 Mn |
| Dec 31, 2022 | -26.45 Mn |
| Sep 22, 2022 | -27.05 Mn |
| Sep 22, 2022 | -27.05 Mn |
| Dec 31, 2021 | -22.46 Mn |
| Dec 31, 2021 | -22.46 Mn |
| Jun 30, 2021 | -14.32 Mn |
| Jun 30, 2021 | -14.32 Mn |
| Mar 31, 2021 | -9.34 Mn |
| Mar 31, 2021 | -9.34 Mn |
| Dec 31, 2020 | -8.55 Mn |
| Dec 31, 2020 | -8.55 Mn |
| Jun 30, 2020 | -3.96 Mn |
| Jun 30, 2020 | -3.96 Mn |
| Mar 31, 2020 | -3.95 Mn |
| Mar 31, 2020 | -3.95 Mn |